236 related articles for article (PubMed ID: 22227861)
1. Homeobox gene expression profile indicates HOXA5 as a candidate prognostic marker in oral squamous cell carcinoma.
Rodini CO; Xavier FC; Paiva KB; De Souza Setúbal Destro MF; Moyses RA; Michaluarte P; Carvalho MB; Fukuyama EE; ; Tajara EH; Okamoto OK; Nunes FD
Int J Oncol; 2012 Apr; 40(4):1180-8. PubMed ID: 22227861
[TBL] [Abstract][Full Text] [Related]
2. Homeobox gene amplification and methylation in oral squamous cell carcinoma.
Rodrigues MFSD; Xavier FCA; Esteves CD; Nascimento RB; Nobile JS; Severino P; de Cicco R; Toporcov TN; Tajara EH; Nunes FD
Arch Oral Biol; 2021 Sep; 129():105195. PubMed ID: 34126417
[TBL] [Abstract][Full Text] [Related]
3.
Zhang J; Wu J; Chen Y; Zhang W
Biochem Cell Biol; 2021 Aug; 99(4):424-434. PubMed ID: 34283652
[TBL] [Abstract][Full Text] [Related]
4. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
[TBL] [Abstract][Full Text] [Related]
5. Knocking-down of CREPT prohibits the progression of oral squamous cell carcinoma and suppresses cyclin D1 and c-Myc expression.
Ma J; Ren Y; Zhang L; Kong X; Wang T; Shi Y; Bu R
PLoS One; 2017; 12(4):e0174309. PubMed ID: 28369091
[TBL] [Abstract][Full Text] [Related]
6. Identification of Novel Candidate Biomarkers for Oral Squamous Cell Carcinoma Based on Whole Gene Expression Profiling.
Kengkarn S; Petmitr S; Boonyuen U; Reamtong O; Poomsawat S; Sanguansin S
Pathol Oncol Res; 2020 Oct; 26(4):2315-2325. PubMed ID: 32468250
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of miR-187 modulates the advances of oral carcinoma by targeting BARX2 tumor suppressor.
Lin SC; Kao SY; Chang JC; Liu YC; Yu EH; Tseng SH; Liu CJ; Chang KW
Oncotarget; 2016 Sep; 7(38):61355-61365. PubMed ID: 27542258
[TBL] [Abstract][Full Text] [Related]
8. Screening and identification of autophagy-related biomarkers for oral squamous cell carcinoma (OSCC) via integrated bioinformatics analysis.
Huang GZ; Lu ZY; Rao Y; Gao H; Lv XZ
J Cell Mol Med; 2021 May; 25(9):4444-4454. PubMed ID: 33837652
[TBL] [Abstract][Full Text] [Related]
9. Identification and Validation of PLOD2 as an Adverse Prognostic Biomarker for Oral Squamous Cell Carcinoma.
Sun Y; Wang S; Zhang X; Wu Z; Li Z; Ding Z; Huang X; Chen S; Jing Y; Zhang X; Ding L; Song Y; Sun G; Ni Y
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944486
[TBL] [Abstract][Full Text] [Related]
10. ZEB1 as an indicator of tumor recurrence for areca quid chewing-associated oral squamous cell carcinomas.
Ho CM; Hu FW; Lee SS; Shieh TM; Yu CH; Lin SS; Yu CC
J Oral Pathol Med; 2015 Oct; 44(9):693-8. PubMed ID: 25367287
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
12. An integrated methylation and gene expression microarray analysis reveals significant prognostic biomarkers in oral squamous cell carcinoma.
Zhao C; Zou H; Zhang J; Wang J; Liu H
Oncol Rep; 2018 Nov; 40(5):2637-2647. PubMed ID: 30226546
[TBL] [Abstract][Full Text] [Related]
13. HOXA1 is overexpressed in oral squamous cell carcinomas and its expression is correlated with poor prognosis.
Bitu CC; Destro MF; Carrera M; da Silva SD; Graner E; Kowalski LP; Soares FA; Coletta RD
BMC Cancer; 2012 Apr; 12():146. PubMed ID: 22498108
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of potential novel biomarkers for oral squamous cell carcinoma.
Zhang M; Chen X; Chen H; Zhou M; Liu Y; Hou Y; Nie M; Liu X
Bioengineered; 2021 Dec; 12(1):8845-8862. PubMed ID: 34606406
[TBL] [Abstract][Full Text] [Related]
15. LncRNA PART1 promotes cell proliferation and inhibits apoptosis of oral squamous cell carcinoma by blocking EZH2 degradation.
Yu Q; Du Y; Wang S; Zheng X
J Biochem; 2021 Sep; 169(6):721-730. PubMed ID: 33725092
[TBL] [Abstract][Full Text] [Related]
16. Overexpression and clinicopathological significance of homeobox gene Quox-1 in oral squamous cell carcinoma.
Zhu F; Li J; Li WX; Liu ZC; Long X
J Biochem Mol Biol; 2004 Nov; 37(6):671-5. PubMed ID: 15607025
[TBL] [Abstract][Full Text] [Related]
17. The role of novel prognostic markers PROX1 and FOXC2 in carcinogenesis of oral squamous cell carcinoma.
Agnihotri NS; Astekar M
J Exp Ther Oncol; 2018 May; 12(3):171-184. PubMed ID: 29790306
[TBL] [Abstract][Full Text] [Related]
18. miR‑543 acts as a novel oncogene in oral squamous cell carcinoma by targeting CYP3A5.
Wang L; Chen W; Zha J; Yan Y; Wei Y; Chen X; Zhu X; Ge L
Oncol Rep; 2019 Sep; 42(3):973-990. PubMed ID: 31322243
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma.
Romani C; Salviato E; Paderno A; Zanotti L; Ravaggi A; Deganello A; Berretti G; Gualtieri T; Marchini S; D'Incalci M; Mattavelli D; Piazza C; Bossi P; Romualdi C; Nicolai P; Bignotti E
Theranostics; 2021; 11(6):2987-2999. PubMed ID: 33456584
[TBL] [Abstract][Full Text] [Related]
20. Aberrantly hypermethylated tumor suppressor genes were identified in oral squamous cell carcinoma (OSCC).
Kim SY; Han YK; Song JM; Lee CH; Kang K; Yi JM; Park HR
Clin Epigenetics; 2019 Aug; 11(1):116. PubMed ID: 31405379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]